inviscan
Inviscan is a privately held Strasbourg-based manufacturer of preclinical PET, CT, and PET/CT imaging systems for small animal research, serving academic institutions, CNRS laboratories, and hospital research centers across Europe and China through direct field sales and an exclusive ultrasound distribution partnership.
- Company typePrivate
- Founded-
- HeadquartersStrasbourg, France
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What inviscan does
Inviscan (operating as inviscan SAS) is a privately held French medical technology company headquartered in Strasbourg that develops and manufactures preclinical imaging systems used in medical research. Its product portfolio centers on PET, CT, and combined PET/CT scanners designed for imaging small animal models ranging from mice and rats to non-human primates. The portfolio includes the IRIS PET/CT and IRIS XL PET/CT dual-modality systems for rodents and large animals respectively, the IRIS HR PET ultra-high-resolution scanner specialized for in-vivo brain research, and the IRIS CT-S and IRIS XL CT high-resolution preclinical CT scanners. The company is also developing novel digital PET detection modules based on new photodetector components and MRI-compatible PET insert instrumentation in partnership with academic institutions.
The business model is primarily capital equipment sales of PET, CT, and PET/CT systems priced on a custom configuration basis, supplemented by recurring revenue from technical service contracts, on-site staff training, and applications support (customized imaging workflows, new tracer development, quantitative dynamic imaging, and cardiac/respiratory gating). A second product line — complete laboratory solutions covering animal preparation, anesthesia, warming, and gating equipment — is bundled with equipment sales. The go-to-market relies on a European field sales organization of Application Specialists and Service Engineers, engagement at scientific conferences, and an exclusive French distribution agreement with S-Sharp Corporation for the Prospect T1 small-animal ultrasound system, which extends the imaging portfolio beyond PET/CT.
Inviscan serves academic and research institutions, university preclinical imaging departments, CNRS laboratories, and hospital research centers conducting in-vivo and ex-vivo studies in oncology, neurology, and cardiac research across France, Italy, and China. Long-standing research ties with IPHC (Institut Pluridisciplinaire Hubert Curien), a CNRS laboratory in Strasbourg, anchor the R&D program. The company has received regional and national French development support from Région Alsace, ADIRA, SEMIA, and Bpifrance, but no institutional venture funding has been disclosed and ownership details are not publicly available.
inviscan firmographics
Firmographics- Name
- inviscan
- Legal name
- inviscan SAS
- Website
- https://inviscan.fr
- Company type
- Private
- Operating status
- Operating
- Short description
- Inviscan is a privately held Strasbourg-based manufacturer of preclinical PET, CT, and PET/CT imaging systems for small animal research, serving academic institutions, CNRS laboratories, and hospital research centers across Europe and China through direct field sales and an exclusive ultrasound distribution partnership.
- Ownership category
- akta.pro rank
inviscan industry classification
Industry- Product category
- Preclinical Imaging Systems
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Irradiation Apparatus Manufacturing (334517)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826), X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844)
- akta.pro primary industry
- Nuclear Medicine & Molecular Imaging (SPECT/PET) (HLAHABAE)
Keywords
Where inviscan is headquartered
LocationHeadquarters
- HQ city
- Strasbourg
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
inviscan business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Preclinical Imaging Hardware Sales: Sale of PET, CT, and PET/CT scanners for preclinical research. Systems include IRIS PET, IRIS CT-S, IRIS XL PET/CT, and IRIS XL CT. Flexible configuration allows upgrades from single-modality to dual-modality systems.
- Service and Support: Technical service for system operation, upgrade, and maintenance. Training for staff on-site. Applications support including imaging workflow customization, tracer development, and quantitative analysis.
- Complete Laboratory Solutions: Animal preparation, anesthesia, warming, gating equipment. Modularized and tailored solutions for specific research applications.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
inviscan product offering
Product offeringCore offering
Inviscan develops and manufactures preclinical imaging systems (PET, CT, and combined PET/CT scanners) for medical research using small animal models including mice, rats, and non-human primates. The company also develops novel MRI-compatible PET insert technology and proprietary digital PET detection modules based on new photodetector components. Systems are configurable from single-modality to dual-modality configurations and are complemented by application support, technical service, and complete laboratory solutions.
Product overview
Inviscan offers a portfolio of preclinical imaging systems for medical research, available as single-modality PET or CT scanners or as integrated dual-modality PET/CT configurations. The IRIS product line includes: IRIS PET/CT and IRIS XL PET/CT for dual-modality imaging; IRIS HR PET for ultra-high resolution brain imaging; IRIS CT-S and IRIS XL CT for standalone CT imaging. The IRIS systems are designed for different animal model sizes—standard IRIS for mice and rats, XL series for large animals including non-human primates. Additionally, Inviscan distributes the Prospect T1 ultrasound system from S-Sharp Corporation. The company also provides comprehensive service offerings including application support, technical service, and complete laboratory solutions.
Differentiator
Problem solved
Functional benefit
Brands
- IRIS PET/CT: Dual modality PET/CT scanner for preclinical research on mice and rats with high sensitivity (>9%) and spatial resolution (~0.9mm)
- IRIS XL PET/CT
- IRIS HR PET
- IRIS CT-S
- IRIS XL CT
- Prospect T1
Products and services
- IRIS PET/CT Dual-modality PET/CT scanner optimized for small animal imaging (mice and rats). Offers sensitivity greater than 9%, spatial resolution near 1mm, sensorless cardiac and respiratory gating, and 4D CT imaging. Configurable as single-modality PET, CT, or dual PET/CT with upgrade path; for preclinical research facilities and academic labs.
- IRIS XL PET/CT Dual-modality PET/CT scanner with large bore size (26 cm) dedicated to preclinical imaging of non-human primates and large animal models. Features high resolution PET (~1mm spatial resolution), high resolution CT (~70 µm), and extended axial FOV greater than 600mm with multiple bed positions.
- IRIS HR PET Compact PET system with ultra-high resolution (0.65mm spatial resolution) designed specifically for in-vivo brain research on mice and rats. Features 3% sensitivity, energy resolution optimization, model-based 3D MLEM/OSEM reconstruction, and list mode acquisition.
- IRIS CT-S State-of-the-art preclinical CT scanner dedicated to high-resolution in-vivo imaging. Offers 30 µm voxel resolution, ultra-fast scan times (under 4 seconds), low dose (under 1mGy), cone beam CT technology, and software-based sensorless cardiac and respiratory gating for 4D imaging.
- IRIS XL CT High-resolution preclinical CT scanner with large bore sizes (26cm for XL-260, 32cm for XL-320) optimized for imaging larger animal models including non-human primates. Features fast scanning (4s ultra-fast mode), low dose capability, extended axial FOV greater than 600mm with multiple bed positions, and integrated breath-holding solution for NHP lung imaging.
- Prospect T1 Ultrasound Small animal ultrasound imaging system distributed by Inviscan in France. Manufactured by S-Sharp Corporation, featuring up to 30 µm spatial resolution, real-time colour Doppler imaging, molecular imaging for perfusion and targeting, and synthetic aperture focusing technique for enhanced resolution.
- Application Support Services Comprehensive imaging services including customized imaging workflow design, tumor model experiments, new tracer development, quantitative dynamic imaging with artery input function, and cardiac/respiratory gating support for preclinical research customers.
- Technical Services System operation support, upgrades, maintenance, and on-site staff training services for Insviscan imaging systems.
- Laboratory Solutions Complete laboratory solutions including animal preparation, anesthesia, warming, gating equipment, and modularized solutions tailored for specific preclinical research applications.
Quantifiable outcome
- PET spatial resolution down to 0.65mm (IRIS HR PET)
- +4 more outcomes
Companies that use inviscan
Customer profileNamed customers14 records
Segments2 records
Ideal customer profiles1 record
inviscan technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
inviscan partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered minor and core.
- University of Pisa (UPisa)minorAcademic research partner in international projects for preclinical imaging technology development and validation.
- IPHC (Institut Pluridisciplinaire Hubert Curien)coreLong-term research partner based in Strasbourg, France. IPHC researchers collaborate on system development, imaging protocols, and serve as a reference site for technology demonstration.
- Region AlsaceminorRegional government support for technology company based in Alsace, France.
- AdiraminorRegional development agency partner supporting company operations.
- SEMIAminorTechnology incubator/partnership supporting startup development in the region.
- IFC CNR (Institute of Clinical Physiology, National Research Council of Italy)minorItalian research institute collaborating on preclinical imaging applications and serving as a reference site for cardiac and imaging studies.
- S-Sharp CorporationcoreInviscan SAS is the exclusive distributor of Prospect High Frequency Ultrasound Imaging Systems in France. This complementary product line extends Inviscan's preclinical imaging portfolio.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
inviscan competitors and assessment
Company assessmentBroad incumbents
- GE HealthCare: GE HealthCare offers preclinical imaging solutions within its broader medical imaging portfolio. Comparable through PET/CT technology overlap but with vastly greater resources and broader market positioning in clinical rather than preclinical segments.
- Siemens Healthineers: Siemens Healthineers is a global medical imaging giant with preclinical PET and PET/CT offerings as part of its broader portfolio. Comparable through overlapping PET technology but operates at vastly larger scale with clinical imaging as primary focus.
Direct peers
- Bruker BioSpin: Bruker is the dominant player in preclinical MRI and offers PET, CT, and PET/CT systems (e.g., Albira Si, SkyScan microCT) for small-animal imaging research. Directly comparable to Inviscan's preclinical PET/CT product line with overlapping customer base in academic research institutions globally.
- Scanco Medical: Scanco Medical is a specialist in high-resolution microCT systems for preclinical bone and tissue imaging research. Directly comparable in the preclinical CT imaging space with overlapping bone, ex-vivo, and small-animal research applications.
- Mediso Medical Imaging Systems: Mediso manufactures preclinical PET, SPECT, and CT systems (nanoScan, MultiScan) for small-animal imaging. Directly competes with Inviscan's IRIS line in the preclinical multimodal imaging market with similar high-resolution specifications and academic customer focus.
- Revvity (formerly PerkinElmer Life Sciences): Revvity offers the IVIS preclinical imaging platform (luminescence, fluorescence, microCT) widely used in academic and pharma research. Comparable preclinical imaging portfolio targeting similar research workflows in oncology and translational research.
- Sedecal USA: Sedecal designs and manufactures preclinical and clinical imaging equipment including CT and PET systems. Comparable in the preclinical X-ray and molecular imaging equipment space with overlapping academic and pharma customers.
- Trifoil Imaging: Trifoil Imaging (formerly Gamma Medica Ideas) specializes in preclinical PET, SPECT, and CT imaging systems. Direct competitor in the high-resolution small-animal imaging market with similar NHP-capable system offerings.
Emerging players
- Aspect Imaging: Aspect Imaging develops compact MRI systems for preclinical and clinical applications. Comparable in preclinical imaging modality coverage with overlap in academic research customer base, though focused on MRI rather than PET/CT.
Others
- S-Sharp Corporation: S-Sharp manufactures the Prospect T1 ultrasound preclinical imaging system that Inviscan distributes in France. An adjacent technology partner rather than direct competitor; relevant as an ecosystem participant in the preclinical imaging market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
inviscan social profiles
Digital presenceinviscan financial estimates
Financial estimateRevenue estimate
Valuation estimate
inviscan leadership team
Management profileNumber of profiles
inviscan funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
inviscan M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about inviscan
What does inviscan do?
Inviscan develops and manufactures preclinical imaging systems (PET, CT, and combined PET/CT scanners) for medical research using small animal models including mice, rats, and non-human primates. The company also develops novel MRI-compatible PET insert technology and proprietary digital PET detection modules based on new photodetector components. Systems are configurable from single-modality to dual-modality configurations and are complemented by application support, technical service, and complete laboratory solutions.
Is inviscan a public or private company?
inviscan is a private company. It is classified as unknown and is currently operating.
When was inviscan founded?
inviscan was founded in -1.
Where is inviscan based?
inviscan is headquartered in Strasbourg, France, in the Europe region.
How does inviscan make money?
Three revenue lines are on record. Preclinical Imaging Hardware Sales are the primary driver. The others are service and Support and complete Laboratory Solutions.
Who are inviscan's main competitors?
Broad incumbents on record are GE HealthCare and Siemens Healthineers. Direct peers are Bruker BioSpin, Scanco Medical, Mediso Medical Imaging Systems, Revvity (formerly PerkinElmer Life Sciences), Sedecal USA and Trifoil Imaging. Aspect Imaging is listed as an emerging player. S-Sharp Corporation is listed as an others.
Does inviscan have an API?
No public API is recorded for inviscan.
What industry is inviscan in?
inviscan's product category is Preclinical Imaging Systems. Its primary akta.pro industry code is HLAHABAE, Nuclear Medicine & Molecular Imaging (SPECT/PET). Its NAICS code is 334510 and its SIC code is 3841.